Dengue Testing Market - Top Companies and Manufacturers

  • Report ID: 3278
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Companies Dominating the Dengue Testing Landscape

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • InBios International, Inc.
    • EUROIMMUN AG
    • CERTEST BIOTEC SL
    • Abnova Corporation
    • ThermoFisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Quest Diagnostics Incorporated
    • DiaSorin Group
    • NovaTec Immundiagnostica GmbH

Browse Key Market Insights with Data Illustration:

In the News

  • May 2021: InBios International, Inc. announced that it had received Emergency Use Authorization for its SCoV-2 Ag Detect Rapid Test from the U.S. Food and Drug Administration (FDA).

  • April 2021: ThermoFisher Scientific announced that it would acquire PPD, Inc. This acquisition would further expand the service offerings of ThermoFisher Scientific to pharma and biotech customers.

  • March 2020: DiaSorin Group signed a licensing and technology transfer agreement with TTP plc. This allows DiaSorin Group to have access to Puckdx, a flexible & low-cost platform developed by TTP for the automation of sample-to-answer diagnostic assays.


Author Credits:  Radhika Pawar


  • Report ID: 3278
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of dengue testing is evaluated at USD 667.34 million.

Dengue Testing Market size was over USD 635.8 million in 2023 and is poised to cross USD 1.38 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. The growing incidences of dengue-related infections and the development of low-cost and reliable testing kits will fuel the market growth.

Asia Pacific is poised to account for largest revenue share by 2036, owing to high prevalence of dengue virus infections in several countries of the region such as Malaysia, Philippines and Vietnam, and the increase in government expenditure on improving healthcare infrastructure along with growing emphasis on carrying out dengue awareness campaigns in the region.

The major players in the market include Abbott Laboratories, InBios International, Inc., EUROIMMUN AG, and CERTEST BIOTEC SL, among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample